
Contract research organizations such as Covance are heading further east through Europe.

Contract research organizations such as Covance are heading further east through Europe.

As the pharmaceutical industry moves further into Central and Eastern Europe and the Commonwealth of Independent States, several standard-setting and regulatory bodies are also increasing collaboration in the region, particularly in Russia.

This article is part of a Special Report on the Emerging Markets of The East, October 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam Molecular Therapeutics appoints CEO; more...

Pharmaceutical Technology Europe
Julian Mosquera, Director of LCP Consulting, advises how pharma companies can make their supply chains leaner.

Pharmaceutical Technology Europe
Despite the economic downturn, Spain's pharmaceutical industry continues to grow - particularly when it comes to biotechnology.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO; more...

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn Group appoints CEO of US business; more...

Equipment and Processing Report
Small-format packaging equipment can provide benefits to the pharmaceutical industry such as quick changeover and low tooling costs. The machines also can shorten the time it takes to bring a product to the market.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more...

ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Pharmacopeial Convention (USP) and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) signed a memorandum of understanding (MOU) last week.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...

Brief pharmaceutical news items for September 2009.

After years of promomting QbD concepts, FDA's ready to take action on nonconformers.

Contract-service providers are expanding their offerings in this slow-growth environment.

Personalized medicine and integrated healthcare delivery require new business and pricing models. This article contains bonus online-exclusive material.

Select contract manufacturing organizations roll out expansions for production of active pharmaceutical ingredients and intermediates.

As new process validation guidelines emerge, industry needs to reinvent how it releases product.

IPEC's new stability testing guide takes into account the full supply chain's storage conditions.

The author reviews the major biopharmaceutical markets' activity and predicts how the markets may evolve.

Scientists from DSM and Kaneka discuss various techniques in this roundtable moderated by Patricia Van Arnum.

Pharmaceutical Technology Europe PTE
Quanticate's Commercial Director explains the ins and outs of outsourcing.

Pharmaceutical Technology Europe
In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.

Pharmaceutical Technology Europe
Increase your chances of success in the biggest market in the world.

Pharmaceutical Technology Europe
Belgium is one of the largest centres for pharmaceutical distribution and has the second highest number of pharma exports per capita worldwide.